|
WLL
WLL
Wellco Health Limited - Wellco launches KGB successfully in Portugal
Wellco Health Limited
(formerly Nungu Trading 279 (Pty) Ltd)
(Incorporated in the Republic of South Africa)
(Registration number 2005/005805/06)
Share code: WLL ISIN: ZAE000071841
("Wellco" or "the company")
WELLCO LAUNCHES KGB SUCCESSFULLY IN PORTUGAL
River Group is authorised to announce that Wellco has successfully launched the
KGB product into Portugal.
The KGB brand was successfully launched into the Portuguese market on the 19th
May 2006. A combination of strong public relations, print and outdoor media and
radio advertising resulted in Wellco"s strategic distribution partner in
Portugal exceeding initial launch performance metrics.
The applicable Portuguese target market comprises 850,000 individuals. Initial
projections forecast that the launch campaign would achieve a 2.5% penetration
over the 3 month launch period. Actual penetration achieved was approximately
7.0% in the first 3 months.
This success has allowed the strategic distribution partner in Portugal to
increase the retail footprint into Spain which is 4 - 5 times larger in
demographic population, retail outlets and has a higher disposable income per
capita. The anticipated launch is end November. Brazil, with its Portuguese base
and strong economic ties, has been targeted as the next market and a due
diligence is currently being performed to assess marketing and retail
distribution options.
Further areas of distribution include the USA and Canada where the product is
currently being registered with the regulatory bodies. This should take 3 to 6
months for registration.
The strong interest in the KGB product by the international market is offering
Wellco a truly global distribution opportunity. The acceptance of the brand by
the international markets has lead to a strong demand from our strategic
partners internationally to distribute further products in our full brand
portfolio.
27 October 2006
Pretoria
Designated Advisor
River Group
Warning: The listing of ordinary shares in the company is on the AltX.
Shareholders are advised of the risks of investing in a company listed on the
AltX. Shareholders are advised that the JSE does not guarantee the viability or
the success of a company listed on the AltX. In terms of the JSE Listings
Requirements a Designated Advisor has to be retained by the company. The
Designated Advisor is required to, inter alia, attend all board meetings held by
the company to ensure that all JSE Listings Requirements and applicable
regulations are complied with, approve the financial director of the company and
guide the company in a competent, professional and impartial manner. If the
company fails to retain a Designated Advisor it must make arrangement to appoint
a new Designated Advisor within 10 business days, failing which the company
faces suspension of trading of its securities. If a Designated Advisor is not
appointed within 30 days of its suspension the company faces the termination of
its listing without an offer to minority shareholders.
Date: 27/10/2006 08:51:20 AM Produced by the JSE SENS Department
| Profile Group (Pty) Ltd. has taken care in preparing all information on this website, but does not accept any liability for errors or out-of-date information. | |||||||||||||
| Other Profile Group sites: FundsData Online (unit trust data) | Profile Group corporate site | |||||||||||||
| [ Terms of Use | Privacy Policy | PAIA manual | FAQs/Help | Site Map | © Copyright Reserved 2026 ] | |||||||||||||
|
|||||||||||||
